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Abstract
Introduction: Pacemaker induced superior vena cava syndrome is an unusual complication of
pacemaker implantation. Endothelial damage caused by repeated trauma from the lead is thought to
be responsible for the stenosis. Malignancy has been historically the most common etiology.
However, the increase in use of indwelling venous catheters and cardiac pacemaker has resulted in
more patients with superior vena cava syndrome of benign etiology.
Case presentation: A 54-year-old female presented with recurrent spasm and swelling of the neck
for the duration of two months. Pacemaker was implanted in 1997 for symptomatic third degree
heart block. It was removed in 2007 due to recurrent infection at the lead site. Computed
tomography of the chest and venogram were performed which showed stenosis at origin of the
superior vena cava with some collateral circulation. She underwent angioplasty by the interventional
radiology and is currently free of symptoms.
Conclusions: Our case highlights a relatively uncommon complication of pacemaker. As a primary
care physician, one should be aware of this unusual complication of pacemaker. Superior vena cava
syndrome should be suspected in patients with history of pacemaker insertion who present to the
primary care physician with neck spasm or neck swelling. Primary care physicians should also be
aware balloon angioplasty is a reasonable primary intervention in selected patient population.
Introduction
SVC syndrome was first described by William Hunter in
1757. Malignant diseases such as bronchial carcinoma,
mediastinal lymphoma have been historically been the
most common malignant etiology and mediastinal
fibrosis has been most common cause of benign etiology.
However, the increase in use of indwelling venous
catheters, cardiac pacemaker and implantable cardioverter
defibrillator has resulted in more patients with SVC
syndrome of benign etiology.
SVC thrombosis with or without stenosis from the
pacemaker leads was described by Kosowsky and Barr in
1972 [1]. The incidence of this condition has been
reported in the literature range from 1 in 650 patients to
1 in 3100 patients [2]. We report a case of SVC stenosis
secondary to pacemaker insertion who underwent
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literature review, our case is a first report of its kind to
indicate this complication occurred after removal of the
pacemaker device.
Case presentation
A 54 year old African American female presented with
history of recurrent swelling of the neck and face for two
months, mainly noticed in the morning time which
resolved later in the day. She was also feeling tightening
spasm in her neck for the same duration. She denied any
shortness of breath, chestp a i no rc o u g h .C l i n i c a l
examination showed minimal edema of the face and
prominent superficial veins of the chest wall and neck
region. She had a history of pacemaker insertion in 1997
for complete heart block in an outside hospital (DDD
pacemaker with triology DDR 2306L, pace setter pace-
maker along with atriventricular leads). Because of
persistent infection of the pacemaker site pacemaker/
wire was removed in 2007 by sternotomy in another
outside hospital. Other past medical history is remarkable
for hypertension, and obstructive sleep apnea.
She has been taking metoprolol and lisinopril for her
hypertension. She smokes 2 packs of cigarettes a day for
the last 26 years and has significant history of alcohol
intake. Current electrocardiogram showed normal sinus
rhythm. Computed tomography (CT) of the chest was
performed first(Figures1,2).Anarm venogramconfirmed
SVC obstruction, with severe stenosis at the origin of SVC
near the junction of azygous vein. Percutaneous endovas-
cular procedures (PTA) was performed by right internal
jugular vein approach by using 12 mm × 4 cm balloon
which was advanced across the stenosis (Figure 3 A-C).
Immediate post angioplasty venogram showed excellent
flow identified in the SVC. The symptoms of superior vena
cava syndrome began to improve immediately after the
angioplasty and she continues to be free of symptoms
2 months after the procedure. A follow up CT scan of the
Figure 1. CT scan with contrast of the chest shows
narrowing of the SVC.
Figure 2. CT scan with contrast shows prominent caliber of
the azygous vein due to collateral flow.
Figure 3. Venogram images of the SVC show, (A). Stenosis
with collateral circulation, (B). Balloon angioplasty of the
stenotic area, (C). Improved flow of contrast in SVC after the
angioplasty.
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community acquired pneumonia which showed patent
stenotic area (Figure 4).
Discussion
The pathogenesis of the SVC stenosis in pacemaker
implanted patients is thought to be from endothelial
disruptioncausedbyrepeated traumafromtheleadsandit
usually occurs above the right atrium [3]. Deposition of
fibrin on the surface of the leads can result in vessel wall
inflammation, fibrosis, thrombus formation and even-
tually these changes lead to venous stenosis and occlusion
[2].Leadinfectionlikeourcase,andretainedleadsincrease
the risk of thrombosis, stenosis and subsequent SVC
syndrome. Lead material, caliber, and access site either by
subclavian or cephalic did not have any impact on stenosis
formation [4,5]. Stenosis due number of leads varies, but
only one study report that increasing number of leads had
been associated with more stenosis formation [6].
The most common clinical presentations are neck, facial
and upper extremity swelling secondary to obstruction of
blood flow in the SVC. Other commonly reported
symptoms are dyspnea on exertion, orthopnea, headache,
dizziness and visual changes. Head and neck swelling and
chest wall venous collaterals are most commonly seen on
clinical examination. However in most of the patients with
pacemakers, swelling presents insidiously because of
chronic process and the development of adequate
collaterals. Because of high association of SVC syndrome
with malignancy, a thorough history and physical
examination should be performed in all cases. Venography
is considered to be the gold standard for diagnosing
venous obstruction [7], and is required before and after
thevascular intervention. Spiral CT venography isalso very
helpful in diagnosing chest vein stenosis [8,9]. Magnetic
resonance angiography (MRA) may also be considered
when contrast venography is contraindicated.
Anticoagulation and thrombolytic agents are used for
pacemaker induced venous thrombosis. It helps in
maintaining the patency of venous collaterals and reduces
thrombus propagation. Low molecular weight or unfrac-
tionated heparin is used along with warfarin, until the INR
is in the therapeutic range (2 to 3). Warfarin is used for 3-
6 months after the episode of thrombosis. Multimodal
approach is evolving recently, which consists of hepar-
inization, transcatheter thrombolytic therapy, followed by
a minimum of three months of warfarin and balloon
angioplasty for treatment of residual stricture [10]. Our
patient had fibrous stenosis without underlying thrombus.
Percutaneous endovascular procedures (PTA) have been
mainly used for the management of SVC stenosis.
Percutaneos balloon angioplasty was first reported by
Sherry et al [11] in 1986. Use of percutaneous translum-
inal angioplasty alone [11-13] in SVC obstruction
management has been described in previous studies.
Combination of PTA with different types of stenting
[13,14,15] for the management of benign SVC stenosis has
also been reported. These techniques are successful in
eliminating or reducing the stenosis which relieves the
symptoms of SVC obstruction and also helps pacemaker
revision if needed. Our patient’s pacemaker was perma-
nently removed prior to this presentation because of
reversal of her complete heart block to normal sinus
rhythm and her current EKG is showed normal sinus
rhythm. Angioplasty does not adversely affect future open
surgical reconstruction [16] and angioplasty has also been
used for surgery failed patients. Open surgery the last
resort of choice, mainly reserved for symptomatic occlu-
sion that does not respond to percutaneous procedures.
Conclusions
Superior vena cava syndrome is a recognized, uncommon
complication of pacemaker implantation. Our case shows
that this condition may occur even after the removal of the
pacemaker. As a primary care physician, one should be
aware of this unusual complication of the pacemaker. In
patients with history of pacemaker insertion who presents
to the primary care physician with neck spasm or neck
swelling, one should suspect SVC syndrome. Primary care
physician should also be aware of balloon angioplasty as
a reasonable primary intervention in selected patient
population.
Abbreviations
CT, computed tomography; DDD, A pacemaker that
senses and stimulates both atrium and ventricle. The
Figure 4. CT scan with contrast shows patent SVC at the site
of previous stenosis after 2 months.
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stimulates both atrium and ventricle. The stimulation rate
is governed by a maximum rate, the rate determined by a
sensor and the minimum rate; EKG, electrocardiogram;
INR, international normalized ratio; MRA, magnetic
resonance angiography; PTA, percutaneous transluminal
angioplasty; SVC, superior vena cava.
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